The effects of Pro-Leu-GlyNH 2 (PLG), administered i.c.v, in doses of 3.5, 35,350 and 3500 pmol, were studied on the a-MPT-induced disappearance of catecholamines in microdissected rat brain nuclei. PLG, dose-dependently, increased dopamine disappearance in the nucleus caudatus and globus pallidus, whereas a decrease in dopamine disappearance was observed in the nucleus dorsomedialis. Noradrenaline disappearance was decreased in the medial septal nucleus, anterior hypothalamic area and lateral amygdala. A tendency towards an increase in noradrenaline disappearance was observed in the nucl. supraopticus. These data show that PLG has a central site of action. The effects of PLG on dopamine disappearance are comparable to those previously found with vasopressin, while the effects of PLG on noradrenaline utilization show a striking similarity with those previously obtained with oxytocin.
INTRODUCTION
The neuropeptide, Pro-Leu-GlyNH2 (PLG), was first isolated from bovine hypothalamic tissue by Nair et al.28 , as a peptide with MSH-release-inhibiting activity. PLG has since then been the subject of numerous behavioural, neuropharmacological, biochemical and clinical studies19,20,21, 43 . The results of many of these studies have suggested that PLG interacts with central dopaminergic systems. However, the available biochemical evidence is not unanimous in support for this suggestion. In most cases only the interaction of PLG with the nigrostriatal dopamine system was investigated. Positive results have been reported on dopamine concentration17, in vitro dopamine synthesis t7, tyrosine hydroxylase activity 33 and the a-MPT-induced disappearance of dopamine33. 44. On the other hand, also negative reports have been published concerning the effects of PLG on these parameters22-24,31. Several factors have to be considered with respect to these conflicting results. These include the dose level, the fact whether an acute or chronic treatment was used, the route of administration (central or peripheral), single dose or dose-response curves, the parameter being measured, the treatment schedule, the sensitivity of the rat strain and the pre-experimental handling.
Up until now little is known concerning an interaction of PLG with other catecholamine-containing neurons in the brain. Recently it was found that PLG also had an effect on hippocampal and hypothalamic noradrenaline-containing neurons34. Therefore in the present study the effect of PLG was studied on central dopaminergic and noradrenergic activity more in detail, by examining the effect of PLG after i.c.v, injection in several doses on the a-MPT-induced disappearance of dopamine and noradrenaline in several microdissected brain nuclei.
METHODS
Male Wistar rats (140-160 g) were used. A polyethylene canula was implanted in the lateral ventricle as described previously 10. After 5 days of recovery and handling, the rats were subjected to the following treatment schedule. An i.p. injection with
